1 cked by haloperidol and clozapine but not by domperidone.

2 received erythromycin, 410 patients received domperidone.

3 pletion rate compared to orally administered domperidone.

4 ime was lower after erythromycin compared to domperidone (13 min versus 22 min, p < 0.001).

5 ocated to either group 1 (omeprazole 20 mg + domperidone 30 mg) or group 2 (omeprazole 20 mg) in an e

6 ent and was antagonized by pretreatment with domperidone (5 mg/kg, intravenous), a D2-like receptor a

7                                              Domperidone, a peripheral dopamine receptor antagonist,

8 tward in the presence of the D(2) antagonist domperidone and is largely absent in the hippocampus of

9 hasone, digoxin, cyclosporin A, ondansetron, domperidone, and loperamide.

10  rate was higher with erythromycin than with domperidone, but there was no difference in the diagnost

11 in pseudoobstruction include metoclopramide, domperidone, cisapride, octreotide, and erythromycin.

12 ompare the efficacy and safety of omeprazole-domperidone combination vs omeprazole monotherapy in gas

13                                   Omeprazole-domperidone combination was more effective than omeprazo

14                             A combination of domperidone, dexamethasona, and chlorpromazine at night

15 cardiac toxicity associated with oral use of domperidone fail to be convincing.

16 rank order of haloperidol > chlorpromazine > domperidone &gt; (+)-butaclamol > (-)-sulpiride = (+)-sulpi

17  was 86% after erythromycin versus 80% after domperidone (p = 0.03).

18 vation) of p44/42 MAPK, which was blocked by domperidone, pertussis toxin, or PD 98059.

19 on using the dopamine D2 receptor antagonist domperidone prevented HCC in tumor-prone C3H/HeN males.

20                            During the 1990s, domperidone was available to US gastroenterologists unde

21 reports demonstrate the superior efficacy of domperidone when compared with placebo and other pharmac